AlanFung:LabNotes/2015/2015-1-15: Difference between revisions
Jump to navigation
Jump to search
>Alan6017518 |
>Alan6017518 |
||
Line 69: | Line 69: | ||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
| width="81" colspan="4" height="15" | (The tube should be labeled ~2014-12-13) | | width="81" colspan="4" height="15" | (The tube should be labeled ~2014-12-13) | ||
| width="213" colspan="4" | (The tube should be labeled ~2014-12-16) | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
| height="15" | Sample | | height="15" | Sample | ||
| Conc. (ng/ul) | |||
| TruSeq Indx | |||
| Volume for 100ng (ul) | |||
| Sample | |||
| Conc. (ng/ul) | | Conc. (ng/ul) | ||
| TruSeq Indx | | TruSeq Indx | ||
Line 81: | Line 86: | ||
| align="center" | 8 | | align="center" | 8 | ||
| align="center" | 3.83 | | align="center" | 3.83 | ||
| NC-1 | |||
| align="center" | 13.73 | |||
| align="center" | 1 | |||
| align="center" | 7.28 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 87: | Line 96: | ||
| align="center" | 3 | | align="center" | 3 | ||
| align="center" | 4.60 | | align="center" | 4.60 | ||
| NC-2 | |||
| align="center" | 16 | |||
| align="center" | 2 | |||
| align="center" | 6.25 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 93: | Line 106: | ||
| align="center" | 7 | | align="center" | 7 | ||
| align="center" | 5.24 | | align="center" | 5.24 | ||
| NC-3 | |||
| align="center" | 16.93 | |||
| align="center" | 4 | |||
| align="center" | 5.91 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 99: | Line 116: | ||
| align="center" | 5 | | align="center" | 5 | ||
| align="center" | 4.97 | | align="center" | 4.97 | ||
| NC-5 | |||
| align="center" | 13.07 | |||
| align="center" | 5 | |||
| align="center" | 7.65 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 105: | Line 126: | ||
| align="center" | 6 | | align="center" | 6 | ||
| align="center" | 4.39 | | align="center" | 4.39 | ||
| NC-6 | |||
| align="center" | 15.33 | |||
| align="center" | 6 | |||
| align="center" | 6.52 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 111: | Line 136: | ||
| align="center" | 1 | | align="center" | 1 | ||
| align="center" | 4.52 | | align="center" | 4.52 | ||
| NC-7 | |||
| align="center" | 13.73 | |||
| align="center" | 7 | |||
| align="center" | 7.28 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 117: | Line 146: | ||
| align="center" | 2 | | align="center" | 2 | ||
| align="center" | 4.66 | | align="center" | 4.66 | ||
| NC-8 | |||
| align="center" | 15.87 | |||
| align="center" | 8 | |||
| align="center" | 6.30 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 123: | Line 156: | ||
| align="center" | 4 | | align="center" | 4 | ||
| align="center" | 4.66 | | align="center" | 4.66 | ||
| NC-9 | |||
| align="center" | 16.53 | |||
| align="center" | 10 | |||
| align="center" | 6.05 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 129: | Line 166: | ||
| align="center" | 9 | | align="center" | 9 | ||
| align="center" | 3.85 | | align="center" | 3.85 | ||
| NC-12 | |||
| align="center" | 14.8 | |||
| align="center" | 13 | |||
| align="center" | 6.76 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 135: | Line 176: | ||
| align="center" | 14 | | align="center" | 14 | ||
| align="center" | 4.03 | | align="center" | 4.03 | ||
| NC-13 | |||
| align="center" | 13.19 | |||
| align="center" | 14 | |||
| align="center" | 7.58 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 141: | Line 186: | ||
| align="center" | 16 | | align="center" | 16 | ||
| align="center" | 4.49 | | align="center" | 4.49 | ||
| NC-14 | |||
| align="center" | 14.93 | |||
| align="center" | 15 | |||
| align="center" | 6.70 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 147: | Line 196: | ||
| align="center" | 15 | | align="center" | 15 | ||
| align="center" | 4.93 | | align="center" | 4.93 | ||
| NC-15 | |||
| align="center" | 13.6 | |||
| align="center" | 16 | |||
| align="center" | 7.35 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 153: | Line 206: | ||
| align="center" | 13 | | align="center" | 13 | ||
| align="center" | 4.05 | | align="center" | 4.05 | ||
| NC-16 | |||
| align="center" | 13.87 | |||
| align="center" | 27 | |||
| align="center" | 7.21 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 159: | Line 216: | ||
| align="center" | 10 | | align="center" | 10 | ||
| align="center" | 5.10 | | align="center" | 5.10 | ||
| NC-17 | |||
| align="center" | 13.47 | |||
| align="center" | 18 | |||
| align="center" | 7.42 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 165: | Line 226: | ||
| align="center" | 11 | | align="center" | 11 | ||
| align="center" | 5.03 | | align="center" | 5.03 | ||
| NC-18 | |||
| align="center" | 14.67 | |||
| align="center" | 19 | |||
| align="center" | 6.82 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 171: | Line 236: | ||
| align="center" | 12 | | align="center" | 12 | ||
| align="center" | 5.21 | | align="center" | 5.21 | ||
| NC-19 | |||
| align="center" | 13.47 | |||
| align="center" | 20 | |||
| align="center" | 7.42 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 177: | Line 246: | ||
| align="center" | 25 | | align="center" | 25 | ||
| align="center" | 4.39 | | align="center" | 4.39 | ||
| NC-20 | |||
| align="center" | 12.79 | |||
| align="center" | 11 | |||
| align="center" | 7.82 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 183: | Line 256: | ||
| align="center" | 20 | | align="center" | 20 | ||
| align="center" | 5.24 | | align="center" | 5.24 | ||
| NC-21 | |||
| align="center" | 12.31 | |||
| align="center" | 12 | |||
| align="center" | 8.12 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 189: | Line 266: | ||
| align="center" | 27 | | align="center" | 27 | ||
| align="center" | 3.95 | | align="center" | 3.95 | ||
| NC-22 | |||
| align="center" | 16 | |||
| align="center" | 21 | |||
| align="center" | 6.25 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 195: | Line 276: | ||
| align="center" | 23 | | align="center" | 23 | ||
| align="center" | 3.38 | | align="center" | 3.38 | ||
| NC-23 | |||
| align="center" | 13.6 | |||
| align="center" | 22 | |||
| align="center" | 7.35 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 201: | Line 286: | ||
| align="center" | 22 | | align="center" | 22 | ||
| align="center" | 3.71 | | align="center" | 3.71 | ||
| NC-24 | |||
| align="center" | 11.97 | |||
| align="center" | 3 | |||
| align="center" | 8.35 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 206: | Line 295: | ||
| align="center" | 14.67 | | align="center" | 14.67 | ||
| align="center" | 18 | | align="center" | 18 | ||
| align="center" | 6.82 | |||
| NC-27 | |||
| align="center" | 14.67 | |||
| align="center" | 9 | |||
| align="center" | 6.82 | | align="center" | 6.82 | ||
Line 213: | Line 306: | ||
| align="center" | 19 | | align="center" | 19 | ||
| align="center" | 5.07 | | align="center" | 5.07 | ||
| NC-29 | |||
| align="center" | 12.96 | |||
| align="center" | 23 | |||
| align="center" | 7.72 | |||
|- style="font-size:12pt" align="center" | |- style="font-size:12pt" align="center" | ||
Line 219: | Line 316: | ||
| align="center" | 21 | | align="center" | 21 | ||
| align="center" | 5.56 | | align="center" | 5.56 | ||
| NC-30 | |||
| align="center" | 15.47 | | align="center" | 15.47 | ||
| align="center" | 25 | | align="center" | 25 |
Revision as of 20:52, 16 January 2015
SeqCap Epi probe pool (UMR v1) hybridization capture on normal and cancer patient WGBS libraries
- Protocol: Dropbox/ZhangLab/Capture/Noi SeqCap Epi probe pool protocol
Background
- There were a number of differences on the experimental protocols between the two batches of data.
- 141112_HiSeq: Noi used the Tang et al RRBS method for end-repair and polishing Noi/NOTES/2014-10-29; capture was done on Noi/NOTES/2014-11-4;
- 141216_HiSeq: Noi used the Kapa Hyper Prep kit Noi/NOTES/2014-11-30; capture was done on Noi/NOTES/2014-12-25
- Noi did the capture experiment: Noi/NOTES/2014-12-25.
- The libraries were sequenced in one HiSeq PE100bp rapid run 141214_SN1001.
- Dinh mapped the reads: Dinh/Dinh_2015/NOTES/2015-1-7.
- Dr. Zhang analyzed the Hiseq Rapid run data, mapping rate is good. But specificity and enrichment factors are much lower than the first experiment
- Kun did the comparison: Kun:LabNotes/MONOD/2015-1-9.
- Kun did additional comparison for the two sets of data, he is sure the first batch of data has good on-target rates but low library complexity, and the second batch was the opposite.
- Kun:LabNotes/MONOD/2015-1-9#Further_comparison_of_the_two_batches_of_library_preparation_and_capturing_experiments.
- Conclusion 1 Plasma DNA needs to be end-polished using the standard library prep protocol such as the one implemented in the Kapa Hyper Prep kit.
- Conclusion 2 The Tang et al scRRBS protocol is based on some assumptions of the DNA fragment ends, which are not applicable to all plasma DNA fragments.
- I just need to repeat the capture experiments on those libraries made in the second batch, then we should be fine.
Experiment | End Repair | Capture | Hiseq Run | Specificity | Enrichment Factors | Complexity | Clonal Rates | Conclusion |
#1 | Tang et al RRBS | 141104 | 141112 | higher | higher | lower | higher | lower complexity and higher clonal rates due to Tang et assumption the DNA fragment ends |
#2 | Kapa Hyper Prep kit | 141225 | 141216 | lower | lower | higher | lower | lower specificity and enrichment due to capture condition |
Task
Locate remaining WGBS libraries, and the NimbleGen capturing reagents
Noi recently re-amplified WGBS libraries of cancer patients and normal control The tubes of the most recent batches should be labeled in December 2014 They all should be in PCR rack (3 of 8-tube strip for cancer patient and 3 of 8-tube strip for normal control) with the cover. Please do not use the sequencing libraries in the yellow PCR rack as those libraries are sequencing libraries from BSPP capture. Library location -20C WGBS from ctDNA of cancer patients were generated using KAPA Hyper Prep Kit They were generated on 2014-12-13 and should be located in the PCR rack with cover
Repeat capturing with optimized capturing conditions
Library Concentration
(The tube should be labeled ~2014-12-13) | (The tube should be labeled ~2014-12-16) | ||||||
Sample | Conc. (ng/ul) | TruSeq Indx | Volume for 100ng (ul) | Sample | Conc. (ng/ul) | TruSeq Indx | Volume for 100ng (ul) |
PCP-9 | 26.13 | 8 | 3.83 | NC-1 | 13.73 | 1 | 7.28 |
PCP-4 | 21.73 | 3 | 4.60 | NC-2 | 16 | 2 | 6.25 |
PCP-8 | 19.07 | 7 | 5.24 | NC-3 | 16.93 | 4 | 5.91 |
PCP-6 | 20.13 | 5 | 4.97 | NC-5 | 13.07 | 5 | 7.65 |
PCP-7 | 22.8 | 6 | 4.39 | NC-6 | 15.33 | 6 | 6.52 |
PCP-2 | 22.13 | 1 | 4.52 | NC-7 | 13.73 | 7 | 7.28 |
PCP-3 | 21.47 | 2 | 4.66 | NC-8 | 15.87 | 8 | 6.30 |
PCP-5 | 21.47 | 4 | 4.66 | NC-9 | 16.53 | 10 | 6.05 |
6P-1 | 26 | 9 | 3.85 | NC-12 | 14.8 | 13 | 6.76 |
6P-8 | 24.8 | 14 | 4.03 | NC-13 | 13.19 | 14 | 7.58 |
6P-10 | 22.27 | 16 | 4.49 | NC-14 | 14.93 | 15 | 6.70 |
6P-9 | 20.27 | 15 | 4.93 | NC-15 | 13.6 | 16 | 7.35 |
6P-5 | 24.67 | 13 | 4.05 | NC-16 | 13.87 | 27 | 7.21 |
6P-2 | 19.6 | 10 | 5.10 | NC-17 | 13.47 | 18 | 7.42 |
6P-3 | 19.87 | 11 | 5.03 | NC-18 | 14.67 | 19 | 6.82 |
6P-4 | 19.2 | 12 | 5.21 | NC-19 | 13.47 | 20 | 7.42 |
7P-8 | 22.8 | 25 | 4.39 | NC-20 | 12.79 | 11 | 7.82 |
7P-3 | 19.07 | 20 | 5.24 | NC-21 | 12.31 | 12 | 8.12 |
7P-10 | 25.33 | 27 | 3.95 | NC-22 | 16 | 21 | 6.25 |
7P-7 | 29.6 | 23 | 3.38 | NC-23 | 13.6 | 22 | 7.35 |
7P-6 | 26.93 | 22 | 3.71 | NC-24 | 11.97 | 3 | 8.35 |
7P-1 | 14.67 | 18 | 6.82 | NC-27 | 14.67 | 9 | 6.82 |
7P-2 | 19.73 | 19 | 5.07 | NC-29 | 12.96 | 23 | 7.72 |
7P-5 | 18 | 21 | 5.56 | NC-30 | 15.47 | 25 | 6.46 |
- Total volume: 169.41ul
- - Re-purified the two pools with 1X AMOPure bead
- - Resuspended each library with 33ul H2O
- - Measure conc. with Qubit dsDNA HS assay using 1ul of purified library pool. Total volume left ~32ul
- - Normal WGBS library pool: conc. = ng/ul --> total amount in 32ul = ng
- - Cancer patient WGBS library pool: conc. = ng/ul --> total amount in 32ul = ng
- - The total amount of the two library pools is close to 1ug as recommended by User guide.
- - Continue to SeqCap hybridization capture